Expectorant Plus Cough Relief
NDC Package 66007-204-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Expectorant Plus Cough Relief is ■ empty entire contents of packet onto tongue and swallow with a glass of water■ for best taste, do not chew granules■ do not take more than 6 doses in any 24-hour periodAge Doseadults and children 12 years and over2 to 4 packets every 4 hourschildren 6 years to under 12 years1 to 2 packets every 4 hourschildren 4 years to under 6 years1 packet every 4 hourschildren under 4 yearsdo not use. Marketed by Capricorn Pharma Inc., this product is identified by NDC 66007-204 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
66007-204-01
Package Description
12 GRANULE in 1 CARTON
Product Code
66007-204
11-Digit Billing Format
66007020401
RxNorm Crosswalk
  • RxCUI: 2122356 - dextromethorphan HBr 5 MG / guaiFENesin 100 MG Oral Granules
  • RxCUI: 2122356 - dextromethorphan hydrobromide 5 MG / guaifenesin 100 MG Oral Granules

Clinical Specifications

Proprietary Name
Expectorant Plus Cough Relief
Dosage Form
-
Usage Information
■ empty entire contents of packet onto tongue and swallow with a glass of water■ for best taste, do not chew granules■ do not take more than 6 doses in any 24-hour periodAge Doseadults and children 12 years and over2 to 4 packets every 4 hourschildren 6 years to under 12 years1 to 2 packets every 4 hourschildren 4 years to under 6 years1 packet every 4 hourschildren under 4 yearsdo not use

Regulatory & Marketing

Labeler Name
Capricorn Pharma Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-06-2010
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66007-204-01 identifies a specific commercial package of 12 granule in 1 carton of Expectorant Plus Cough Relief, labeled by Capricorn Pharma Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Capricorn Pharma Inc. on August 06, 2010. The current certification is valid through December 31, 2017.

How is this Capricorn Pharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66007020401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66007-204-01
11-Digit CMS (5-4-2)
66007-0204-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.